Dr. Kedar Prasad

Dr. Kedar PrasadDr. Kedar PrasadDr. Kedar Prasad

Dr. Kedar Prasad

Dr. Kedar PrasadDr. Kedar PrasadDr. Kedar Prasad
  • Home
  • Biography
  • Accolades
  • Works
    • Books
    • Papers
  • Videos
  • More
    • Home
    • Biography
    • Accolades
    • Works
      • Books
      • Papers
    • Videos

  • Home
  • Biography
  • Accolades
  • Works
    • Books
    • Papers
  • Videos

Honors and Awards

○ Invited to become a member of the European Society of Medicine, London, 2026.

○ Invited to become a member of The Royal Society of Medicine, London, 2017.

○ A prize for the best research paper of 2001 by the Journal of the American College of Nutrition.

○ Delivered the 1999 Harold Harper Lecture at the American College for Advancement of Medicine.

○ A prize for the best review of 1999 by the Journal of the American College of Nutrition.

○ A prize for the best review of 1998 by the Journal of the American College of Nutrition.

○ Invited by the Nobel Committee to nominate a candidate for the Nobel Prize in Medicine, 1982.

Accolades & Achievements

○ Awarded 10 U.S. patents related to micronutrient research.


○ Received multi-million-dollar research funding from the National Institutes of Health to study human health. 

○ Granted $12.5 million by the U.S. Congress to advance research in collaboration with the U.S. Military, NASA, and other agencies on the role of micronutrients in human health.

○ Earned the distinction of becoming the world’s first Ph.D. in Radiation Biology (University of Iowa, 1963). 

○ Discovered the anti-cancer properties of Vitamin E Succinate. 

○ Identified butyric acid—a short-chain fatty acid produced by gut fermentation—as a natural anti-cancer agent. 

Credentials & Professional Experience

○ Professor, University of Colorado School of Medicine (30+ years) 


○ Invited Member, Nobel Prize Nominating Committee (Medicine category) 

○ President, International Society for Nutrition and Cancer (1994- 2002) 

○ Vice President, International Society of Cancer and Nutrition (1990-1994) 

○ Invited Member, Royal Society of Medicine, London 

○ Completed postdoctoral training at Brookhaven National Laboratory, Long Island, NY 

Patents

 7 issued patents support Dr. Prasad’s formulations: 3 product-issued patents and 3 product-pending patents. Dr. Prasad’s formulations, including Micro Daily, are among the most patent-supported micronutrient formulations available. 

Patent Pending

Energy Boost 

GLP-1 Boost 

U.S. Patent 12,447,174

 Date: October 21, 2025

“Micro Daily EMF protects against oxidative and inflammatory damage, and acute and late adverse effects of EMF radiation”

U.S. Patent: 11,938,100

 Date: March 26, 2024

“Micro Daily-children gummy for optimal growth, development, and health”

U.S. Patent: 11,819,538

 Date: November 21, 2023

“Collagen Daily with enzyme inhibitors for anti-aging”

U.S. Patent: 8,221,799

 Date: July 17, 2012

“Multiple Antioxidant Optimal

Health/Veteran’s Ultimate Complete

Formulations”

U.S. Patent: 7,635,469

 Date: December 22, 2009 

“Micronutrient Formulations for Hearing Health”Add a description about this item

U.S. Patent: 7,628,984

 Date: December 8, 2009

“Micronutrient Formulations for

Pulmonary and Heart Health”

U.S. Patent: 7,605,145

 Date: October 20, 2009

“Micronutrient Formulations for

Treatment of Diabetes Mellitus”

U.S. Patent: 7,449,451

 Date: November 11, 2008

“Use of Multiple Antioxidant Micronutrients

as Systemic Biological Radio-protective Agents 

Against Potential Ionizing Radiation Risks”

U.S. Patent: 7,399,755

 

Date: July 15, 2008

“Formulations Comprising Multiple

Dietary and Endogenously Made

Antioxidants and B-Vitamins and

Use of Same”

U.S. Patent: 6,849,613

Date: February 1, 2000

“Multiple Antioxidant Micronutrients”

Funding

 NIH-R01-NS29982 - Principal Investigator. Neurodegenerative diseases and neural cell transplants. 2/1/96 to 1/31/01, $ 1,853,496 (total, including indirect cost). 

Neurodegenerative mechanisms in Alzheimer's disease, 5/1/000 to 

4/30/2005, $ 2,329,121 (total, including indirect cost).

  NIH-RO1 NS38647 - Principal Investigator. Potential clinical implications of cAMP in neural tumors. 5/1/1999 to 2/29/2004, $ 1,849,777 (total, including indirect cost). 

Shafroth Memorial Fund: $5,500 per year. 

Copyright © 2026 Dr. Kedar Prasad - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept